DataVXSmallPaper
journal article·2024-03Open access

Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy (Small 10/2024)

Dhawal Chobisa, Anbukkarasi Muniyandi, Kamakshi Sishtla, Timothy W. Corson, Yoon Yeo

Small· Volume 20· Issue 10
Publisher pageOpen full text
Source abstract

Abstract

Ocular Neovascularization Therapy In article number 2306479, Timothy W. Corson, Yoon Yeo, and co-workers encapsulated griseofulvin in polymeric microparticles optimized for intravitreal injection for local and sustained delivery to the eye. The antiangiogenic drug is released over six weeks to block choroidal neovascularization, for potential therapy of neovascular age-related macular degeneration.
Source: openalex_inverted_index · Quality: baseline

Research context

Polymers

OpenAlex topics: Corneal Surgery and Treatments · Glaucoma and retinal disorders · Retinal Diseases and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Industrial and Molecular Pharmaceutics Purdue University 575 West Stadium Avenue West Lafayette IN 47907 USA

Integrated Product Development Organization Innovation Plaza Dr. Reddy's Laboratories Hyderabad 500050 India

Departments of Pharmacology & Toxicology and Ophthalmology Indiana University School of Medicine 1160 West Michigan Street Indianapolis IN 46202 USA

Weldon School of Biomedical Engineering Purdue University 206 S Martin Jischke Dr. West Lafayette IN 47907 USA

References

Reference metadata was not supplied for this record.